Eton Pharmaceuticals (ETON) Competitors $17.19 -0.12 (-0.69%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$17.20 +0.00 (+0.03%) As of 09/2/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETON vs. DYN, APGE, TWST, BEAM, CDTX, IMCR, BHVN, WVE, AUPH, and TVTXShould you be buying Eton Pharmaceuticals stock or one of its competitors? The main competitors of Eton Pharmaceuticals include Dyne Therapeutics (DYN), Apogee Therapeutics (APGE), Twist Bioscience (TWST), Beam Therapeutics (BEAM), Cidara Therapeutics (CDTX), Immunocore (IMCR), Biohaven (BHVN), WAVE Life Sciences (WVE), Aurinia Pharmaceuticals (AUPH), and Travere Therapeutics (TVTX). These companies are all part of the "pharmaceutical products" industry. Eton Pharmaceuticals vs. Its Competitors Dyne Therapeutics Apogee Therapeutics Twist Bioscience Beam Therapeutics Cidara Therapeutics Immunocore Biohaven WAVE Life Sciences Aurinia Pharmaceuticals Travere Therapeutics Eton Pharmaceuticals (NASDAQ:ETON) and Dyne Therapeutics (NASDAQ:DYN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment. Which has more risk & volatility, ETON or DYN? Eton Pharmaceuticals has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Dyne Therapeutics has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Is ETON or DYN more profitable? Dyne Therapeutics has a net margin of 0.00% compared to Eton Pharmaceuticals' net margin of -7.10%. Eton Pharmaceuticals' return on equity of -0.73% beat Dyne Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Eton Pharmaceuticals-7.10% -0.73% -0.22% Dyne Therapeutics N/A -64.12%-56.75% Does the media prefer ETON or DYN? In the previous week, Dyne Therapeutics had 9 more articles in the media than Eton Pharmaceuticals. MarketBeat recorded 11 mentions for Dyne Therapeutics and 2 mentions for Eton Pharmaceuticals. Eton Pharmaceuticals' average media sentiment score of 1.77 beat Dyne Therapeutics' score of 1.40 indicating that Eton Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Eton Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Dyne Therapeutics 8 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in ETON or DYN? 27.9% of Eton Pharmaceuticals shares are held by institutional investors. Comparatively, 96.7% of Dyne Therapeutics shares are held by institutional investors. 14.9% of Eton Pharmaceuticals shares are held by company insiders. Comparatively, 20.8% of Dyne Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better valuation and earnings, ETON or DYN? Eton Pharmaceuticals has higher revenue and earnings than Dyne Therapeutics. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than Dyne Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEton Pharmaceuticals$39.01M11.82-$3.82M-$0.16-107.44Dyne TherapeuticsN/AN/A-$317.42M-$3.86-3.50 Do analysts prefer ETON or DYN? Eton Pharmaceuticals presently has a consensus target price of $29.67, indicating a potential upside of 72.58%. Dyne Therapeutics has a consensus target price of $34.07, indicating a potential upside of 152.35%. Given Dyne Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Dyne Therapeutics is more favorable than Eton Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eton Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Dyne Therapeutics 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 3 Strong Buy rating(s) 3.06 SummaryDyne Therapeutics beats Eton Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ETON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ETON vs. The Competition Export to ExcelMetricEton PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$464.21M$3.12B$5.74B$9.77BDividend YieldN/A2.28%6.66%4.50%P/E Ratio-107.4420.8682.9826.39Price / Sales11.82396.75537.51110.52Price / CashN/A43.5325.7028.92Price / Book19.318.1011.056.58Net Income-$3.82M-$53.35M$3.28B$265.84M7 Day Performance-0.52%-0.29%-0.17%-0.26%1 Month Performance21.66%9.18%8.35%5.82%1 Year Performance273.70%10.11%53.92%22.47% Eton Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ETONEton Pharmaceuticals2.5914 of 5 stars$17.19-0.7%$29.67+72.6%+273.7%$464.21M$39.01M-107.4420News CoveragePositive NewsDYNDyne Therapeutics3.7825 of 5 stars$13.00+3.3%$34.07+162.1%-70.7%$1.79BN/A-3.37100News CoveragePositive NewsAPGEApogee Therapeutics3.2143 of 5 stars$36.94-3.5%$99.00+168.0%-26.0%$1.76BN/A-8.9491News CoveragePositive NewsTWSTTwist Bioscience3.9012 of 5 stars$27.39-4.2%$49.40+80.4%-39.3%$1.73B$312.97M-18.89990Positive NewsBEAMBeam Therapeutics2.3741 of 5 stars$16.44-1.2%$48.45+194.7%-38.9%$1.68B$60.27M-3.65510Positive NewsCDTXCidara Therapeutics3.7352 of 5 stars$64.13-3.4%$64.14+0.0%+436.5%$1.68B$1.27M-5.7690Positive NewsIMCRImmunocore1.5946 of 5 stars$32.59-1.0%$56.89+74.6%-10.1%$1.66B$310.20M-81.48320News CoveragePositive NewsBHVNBiohaven3.8468 of 5 stars$14.96-4.2%$54.23+262.5%-59.7%$1.65BN/A-1.95239Trending NewsAnalyst ForecastWVEWAVE Life Sciences4.5567 of 5 stars$9.94-2.1%$20.27+103.9%+67.6%$1.62B$108.30M-11.04240AUPHAurinia Pharmaceuticals2.8003 of 5 stars$12.14-1.1%$12.00-1.2%+71.5%$1.62B$235.13M28.23300News CoveragePositive NewsTVTXTravere Therapeutics1.9853 of 5 stars$17.23-3.9%$32.21+87.0%+91.7%$1.60B$233.18M-8.45460News CoverageAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies DYN Alternatives APGE Alternatives TWST Alternatives BEAM Alternatives CDTX Alternatives IMCR Alternatives BHVN Alternatives WVE Alternatives AUPH Alternatives TVTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ETON) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ETON Stock Alerts